This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million. CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023. CI
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment MT
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares MT
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan. CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.
More charts
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
33.68 CNY
Average target price
61.61 CNY
Spread / Average Target
+82.93%
Consensus
  1. Stock Market
  2. Equities
  3. 603882 Stock
  4. News Guangzhou Kingmed Diagnostics Group Co., Ltd.
  5. UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keeps at Buy